Division of Pulmonary, Allergy, and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Palliative and Advanced Illness Research (PAIR) Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
JAMA Netw Open. 2020 Feb 5;3(2):e200038. doi: 10.1001/jamanetworkopen.2020.0038.
Despite a growing recognition of the increased mortality risk among sepsis survivors, little is known about the patterns of end-of-life care among this population.
To describe patterns of end-of-life care among a national sample of sepsis survivors and identify factors associated with long-term mortality risk and hospice use.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study assessed sepsis survivors who were Medicare fee-for-service beneficiaries discharged to home health care using national Medicare administrative, claims, and home health assessment data from 2013 to 2014. The initial and final primary analyses were conducted in July 2017 and from July to August 2019, respectively.
Sepsis hospital discharge and 1 or more home health assessments within 1 week.
Outcomes were 1-year mortality among all sepsis survivors and hospitalization in the last 30 days of life, death in an acute care hospital, and hospice use among decedents. Multivariate logistic regression was used to identify factors associated with 1-year mortality and hospice use.
Among 87 581 sepsis survivors who were Medicare fee-for-service beneficiaries discharged to home health care, 49 323 (56.3%) were aged 75 years or older, 69 499 (79.4%) were non-Hispanic white, and 48 472 (55.3%) were female. Among the total survivors, 24 423 (27.9%) people died within 1 year of discharge, with a median (interquartile range) survival time of 119 (51-220) days. Among these decedents, 16 684 (68.2%) were hospitalized in the last 30 days of life, 6560 (26.8%) died in an acute care hospital, and 12 573 (51.4%) were enrolled in hospice, with 5729 (45.6%) using hospice for 7 or fewer days. Several factors were associated with 1-year mortality, including a cancer diagnosis (odds ratio [OR], 3.66; 95% CI, 3.50-3.83; P < .001), multiple dependencies of activities of daily living or instrumental activities of daily living (OR, 2.80; 95% CI, 2.57-3.05; P < .001), and an overall poor health status (OR, 2.21; 95% CI, 2.01-2.44; P < .001) documented on home health assessment. Among the decedents, cancer was associated with hospice use (OR, 2.25; 95% CI, 2.11-2.41; P < .001), patients aged 85 years or older (OR, 1.49; 95% CI, 1.37-1.61; P < .001), and living in an assisted living setting (OR, 1.93; 95% CI, 1.69-2.19; P < .001).
The findings of this study suggest that death within 1 year after sepsis discharge may be common among Medicare beneficiaries discharged to home health care. Although 1 in 2 decedents used hospice, aggressive care near the end of life and late hospice referral were common. Readily identifiable risk factors suggest opportunities to target efforts to improve palliative and end-of-life care among high-risk sepsis survivors.
尽管人们越来越认识到脓毒症幸存者的死亡率风险增加,但对于这一人群的临终关怀模式知之甚少。
描述全国脓毒症幸存者的临终关怀模式,并确定与长期死亡风险和临终关怀使用相关的因素。
设计、地点和参与者:本队列研究评估了 Medicare 按服务收费受益人的脓毒症幸存者,这些患者出院后接受家庭健康护理,使用了 2013 年至 2014 年的全国 Medicare 管理、索赔和家庭健康评估数据。最初和最终的主要分析分别于 2017 年 7 月和 2019 年 7 月至 8 月进行。
脓毒症住院和出院后一周内进行 1 次或多次家庭健康评估。
所有脓毒症幸存者的 1 年死亡率、生命最后 30 天的住院、急性护理医院死亡以及死者的临终关怀使用。多变量逻辑回归用于确定与 1 年死亡率和临终关怀使用相关的因素。
在出院接受家庭健康护理的 87581 名 Medicare 按服务收费受益的脓毒症幸存者中,49323 名(56.3%)年龄在 75 岁或以上,69499 名(79.4%)是非西班牙裔白人,48472 名(55.3%)为女性。在所有幸存者中,24423 人(27.9%)在出院后 1 年内死亡,中位(四分位间距)生存时间为 119(51-220)天。在这些死者中,16684 人(68.2%)在生命的最后 30 天住院,6560 人(26.8%)在急性护理医院死亡,12573 人(51.4%)接受临终关怀,其中 5729 人(45.6%)使用临终关怀的时间为 7 天或更短。一些因素与 1 年死亡率相关,包括癌症诊断(比值比[OR],3.66;95%CI,3.50-3.83;P<0.001)、日常生活活动或工具性日常生活活动的多重依赖(OR,2.80;95%CI,2.57-3.05;P<0.001)和整体较差的健康状况(OR,2.21;95%CI,2.01-2.44;P<0.001),这些情况都记录在家庭健康评估中。在死者中,癌症与临终关怀使用相关(OR,2.25;95%CI,2.11-2.41;P<0.001)、85 岁或以上的患者(OR,1.49;95%CI,1.37-1.61;P<0.001)和居住在辅助生活环境中的患者(OR,1.93;95%CI,1.69-2.19;P<0.001)。
这项研究的结果表明,脓毒症出院后 1 年内死亡可能在 Medicare 出院接受家庭健康护理的患者中较为常见。尽管每 2 个死者中就有 1 人使用临终关怀,但临终关怀的激进护理和晚期临终关怀转诊很常见。容易识别的风险因素表明,有机会针对高危脓毒症幸存者改善姑息治疗和临终关怀。